SORICIMED BIOPHARMA INC.

Profile

Company Names

SORICIMED BIOPHARMA INC.

Addresses

18 BOTSFORD STREET, SUITE 201, MONCTON, A3 E1C 4W7

Phone Numbers

1(506)872-2181

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

NEW BRUNSWICK, CANADA

Total Amount Raised:

$2,884,233.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-07-23 
$2,775,233.00 
$3,732,179.00 
$956,946.00 
Equity 
1
2011-09-30 
$109,000.00 
$109,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CAMILLE 
 
BELLIVEAU 
DIRECTOR
SORICIMED BIOPHARMA INC.
ROBERT 
 
BRUCE 
EXECUTIVE OFFICER
BLUE COD TECHNOLOGIES, INC.   |  ZYLO MEDIA, LLC   |  FOREST HOLDCO LLC   |  SPECIALTY PHYSICIANS SURGICENTER OF KANSAS CITY, LLC   |  VISTA BANCSHARES, INC.   |  SORICIMED BIOPHARMA INC.
VAUGHN 
 
EMBRO-PANTELONY 
DIRECTOR
SORICIMED BIOPHARMA INC.
PAUL 
 
GUNN 
EXECUTIVE OFFICER, DIRECTOR
SORICIMED BIOPHARMA INC.
SUSAN 
 
HICKS 
DIRECTOR
SORICIMED BIOPHARMA INC.
TOM 
 
REEVES 
DIRECTOR
SORICIMED BIOPHARMA INC.
MARC 
 
RUBIN 
DIRECTOR
SURFACE LOGIX INC   |  INFORMOUS, INC.   |  CURIS INC   |  CANVAS SOLUTIONS INC   |  GEMMUS PHARMA INC.   |  PATTISON COLE LLC   |  TITAN PHARMACEUTICALS INC   |  SORICIMED BIOPHARMA INC.   |  MEDICINE MAN TECHNOLOGIES, INC.
JACK 
 
STEWART 
EXECUTIVE OFFICER, DIRECTOR
SORICIMED BIOPHARMA INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-01-19
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-23 
2022-01-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-23 
2011-10-18
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2011-09-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NONE
NONE